Table 3

Comparison of transfused blood products between overtransfused and non-overtransfused patients

Total
(n=140)		Overtransfused
(n=61)		Non-overtransfused
(n=79)		P value
pRBC
 Pre-MTP Ux pRBC2.0 (8.0)2.0 (5.0)2.0 (8.0)0.374
 Total pRBCs during MTP phase (Ux+MTP)5.0 (52.0)6.0 (32)5.0 (52.0)0.882
 Additional pRBC after MTP conclusion2.0 (43.0)0.0 (40.0)3.0 (43.0)0.052
 Total pRBC for hospital stay8.5 (74.0)7.0 (50.0)10.0 (74)0.186
Plasma
 Total plasma from MTP3.0 (30.0)3.0 (21.0)2.0 (30.0)0.806
 Additional plasma after MTP conclusion0.0 (25.0)0.0 (9.0)0.0 (25.0)0.206
 Total plasma for hospital stay4.0 (51.0)4.0 (29.0)4.0 (51.0)0.644
Platelets
 Total platelets from MTP1.0 (5.0)1.0 (4.0)1.0 (5.0)0.520
 Additional platelets after MTP conclusion0.0 (10.0)0.0 (9.0)0.0 (10.0)0.392
 Total platelets for hospital stay1.0 (15.0)1.0 (12.0)1.0 (15.0)0.365
Cryoprecipitate
 Total cryoprecipitate from MTP0.0 (5.0)0.0 (3.0)0.0 (5.0)0.894
 Additional cryoprecipitate after MTP conclusion0.0 (4.0)0.0 (4.0)0.0 (3.0)0.326
 Total cryoprecipitate for hospital stay0.0 (6.0)0.0 (6.0)0.0 (6.0)0.646

  • Variables are reported as medians (IQR).

  • P values were extracted from t-test or Mann-Whitney test.

  • MTP, massive transfusion protocol; pRBCs, packed red blood cells; Ux, uncrossmatched.